Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether imatinib is effective in the treatment of
primary and recurrent dermatofibrosarcoma protuberans (DFSP).